Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma
References (27)
- et al.
Cancer immunotherapy using local interleukin-2 administration
Immunol. Lett.
(1987) - et al.
Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T-lymphocytes and macrophages
Immunobiology
(1992) The major causes for condemnation of meat in NSW
Aust. Vet. J.
(1960)Squamous-cell carcinoma of the vulva of cattle in Kenya
Res. Vet. Sci.
(1964)- et al.
Effective immunotherapy with local low doses of Interleukin-2
In Vivo
(1991) - et al.
Tumor immunotherapy with interleukin-2 and leucocytes
Res. Monogr. Immunol.
(1987) - et al.
Bovine ocular squamous cell carcinoma: an epidemiological perspective
Can. J. Comp. Med.
(1985) The natural history of bovine papillomavirus infections
- et al.
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination
Vet. Rec.
(1990) - et al.
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types
Vet. Rec.
(1990)
Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin-2
Cancer Res.
(1985)
Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin-2
Cancer Res.
(1989)
Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour
Cancer Immunol. Immunother.
(1991)
Cited by (28)
Animal models for the discovery of therapeutic and prophylactic measure against HPV-induced malignancies
2022, Immunopathology, Diagnosis and Treatment of HPV induced MalignanciesBovine Ocular Squamous Cell Carcinoma
2010, Veterinary Clinics of North America - Food Animal PracticeCitation Excerpt :Another study reported that 61% of 21 animals with an enlarged subparotid lymph node had regional lymph node metastases and 6 of these animals also had lung metastasis.15 Many therapeutic protocols have been described for OSCC in different primary sites, and they have varying levels of difficulty, required equipment, and results.12,15,41,46–55 Previously described options include surgical excision, cryotherapy, radiofrequency hyperthermia, immunotherapy, chemotherapy, and radiation therapy.
Interleukin 2 (IL-2) therapy: Potential advantages of locoregional versus systemic administration
1999, Cancer Treatment ReviewsVaccination against papillomavirus in cattle
1997, Clinics in DermatologyAre recombinant interleukins more or less therapeutically effective than their exogenous inducers?
1994, Biomedicine and Pharmacotherapy
Copyright © 1994 Published by Elsevier B.V.